(Alliance News) - Polarean Imaging PLC on Tuesday said it has submitted a new phase 3 clinical trial protocol to the US Food & Drug Administration, to support an expanded remit for Xenoview.

As traditional development assistance dwindles, Africa turns to India for vital healthcare partnerships, leveraging ...

The human brain ages less than thought and in layers - at least in the area of the cerebral cortex responsible for the sense of touch. Researchers at ...

A new study published in Developmental Cognitive Neuroscience provides initial evidence that differences in brain chemistry ...

OSU President Jim Hess said construction of a state-of-the-art veterinary teaching hospital "sends a powerful message: Oklahoma State is ready to lead.” ...

Marketed as a preventative health tool, a full-body MRI (magnetic resonance imaging) is a non-invasive medical scan that ...

A study found that people with congestive heart failure have different microbes on their tongues than people without the ...

Recent studies have examined the relationship between the drug and psychoses and looked at how the brain responds to the ...

Known for faithfully recreating the King of Rock ’n’ Roll’s signature sound, Allen’s high-energy performance will include a ...

The full 15-member North Carolina Court of Appeals will not hold a rehearing in a certificate-of-need dispute involving a ...